Xylem Inc.'s Stock Analysis

Xylem Issues $1 Billion in Senior Notes for Debt Repayment

Xylem Inc. has completed a public offering of $1 billion in senior notes, comprising $500 million of 5.200% Senior Notes due in 2033 and $500 million of 5.450% Senior Blue Notes due in 2036. These notes are senior unsecured obligations and will pay interest semiannually, beginning in December 2026. The company plans to use the proceeds from the 2033 Notes to repay existing senior notes maturing in November 2026 and will allocate the proceeds from the 2036 Blue Notes to eligible blue projects.

The notes are governed by a senior indenture that includes covenants limiting the company's ability to incur additional debt or engage in certain transactions. In the event of a change of control accompanied by a downgrade in ratings, Xylem will be required to repurchase the notes at a premium. The offering was conducted under a registration statement and involved several financial institutions as underwriters.

May 29, 2026 16:15:56

Xylem Annual Meeting Approves Key Shareholder Proposals

On May 14, 2026, Xylem Inc. held its Annual Meeting of Shareholders, with 212,209,479 shares represented, accounting for 88.12% of the outstanding common stock as of March 19, 2026. Shareholders elected nine directors for a one-year term and ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2026.

Additionally, shareholders approved an advisory resolution on the compensation for the Company’s named executive officers and implemented the Xylem Inc. 2026 Employee Stock Purchase Plan. These decisions may influence investor confidence and the company’s operational direction moving forward.

May 18, 2026 16:19:58

Xylem Reports First Quarter 2026 Financial Results and Guidance

Xylem Inc. reported financial results for the first quarter of 2026, with total revenue reaching $2.1 billion, a 3% increase on a reported basis, while orders amounted to $2.2 billion, also up 3% reported but flat organically. The company's earnings per share were $0.79, reflecting a 14% rise, and adjusted earnings per share were $1.12, up 9%. The net income attributable to Xylem for the quarter was $193 million, with a net income margin of 9.1%, which increased by 90 basis points compared to the previous year, driven by strong operational performance and a reduction in estimated losses from business sales, despite higher restructuring costs.

For the full year 2026, Xylem anticipates revenue between $9.2 billion and $9.3 billion, indicating a growth of 2% to 3% on a reported basis. The company expects an adjusted EBITDA margin of approximately 22.9% to 23.3%, which would be an increase of 70 to 110 basis points from 2025. Adjusted earnings per share for the year are projected to be between $5.35 and $5.60, aligning with previous guidance. The company is also maintaining its expectation for a free cash flow margin of approximately 10.2% to 11.0%.

Apr 28, 2026 07:03:33

Xylem Announces New $1.5 Billion Share Repurchase Program

Xylem Inc. has adopted a new share repurchase program, authorized by its Board of Directors on February 25, 2026. This program allows the company to repurchase up to $1.5 billion of its common stock, with no expiration date specified. The repurchases can occur through open market purchases or other methods, adhering to applicable laws and regulations.

The new program does not require Xylem to buy a specific amount of common stock and can be suspended at the company's discretion. This flexibility in the program could affect the company's stock price, depending on market conditions and the company's decisions regarding share repurchases.

Feb 25, 2026 16:20:27

Xylem Reports Fourth Quarter and Full Year 2025 Results

Xylem Inc. reported its financial results for the fourth quarter and fiscal year ending December 31, 2025. The company achieved fourth-quarter revenue of $2.4 billion, reflecting a 6% increase from the previous year, driven by a 9% rise in orders. Earnings per share for the quarter were $1.37, a 2% increase, with adjusted earnings per share at $1.42, up 20%. For the full year, Xylem's revenue reached $9 billion, a 6% increase, while adjusted earnings per share were reported at $5.08, up 19%. The company declared a first-quarter dividend of $0.43 per share, marking an 8% increase compared to the previous year.

Looking ahead, Xylem anticipates full-year 2026 revenue in the range of $9.1 to $9.2 billion, representing a 2% to 4% organic growth. The company expects its adjusted EBITDA margin for 2026 to be between 22.9% and 23.3%, indicating a potential increase from 2025 levels. Xylem's focus on simplifying its product portfolio and addressing water challenges is aimed at sustaining profitable growth. The company highlighted strong operational performance, supported by productivity gains and price realization, while also noting a slight decrease in net income margin for the fourth quarter.

Feb 10, 2026 07:02:34

Xylem Reports Third Quarter Earnings and Raises Revenue Guidance

Xylem Inc. reported third-quarter 2025 revenue of $2.3 billion, marking an 8% increase on a reported basis and a 7% increase organically. Earnings per share rose to $0.93, a 4% increase from the previous year, while adjusted earnings per share reached $1.37, reflecting a 23% growth. The company noted strong performance across all segments, particularly in Measurement and Control Solutions and Water Solutions and Services, contributing to a record adjusted EBITDA margin of 23.2%.

The company has raised its full-year 2025 revenue guidance to approximately $9.0 billion, up from previous estimates of 4-5% growth to now predicting 5-6% growth. Adjusted earnings per share guidance has also been increased to a range of $5.03 to $5.08, up from $4.70 to $4.85. Xylem expects an adjusted EBITDA margin of approximately 22.0 to 22.3%, indicating a solid improvement from 2024 levels, while maintaining a free cash flow margin of around 9 to 10%.

Oct 28, 2025 07:03:50

Xylem Reports Strong Second Quarter Financial Performance

Xylem Inc. reported its financial results for the second quarter of 2025, achieving a revenue of $2.3 billion, which reflects a 6% increase on both reported and organic bases. The company also reported earnings per share (EPS) of $0.93, up 16% from the previous year, with adjusted EPS reaching $1.26, also a 16% increase. The net income for the quarter was $226 million, representing a net income margin of 9.8%. The adjusted EBITDA margin improved to 21.8%, driven by productivity savings and strong pricing strategies.

In light of its strong performance, Xylem has raised its full-year guidance for 2025, now forecasting revenue between $8.9 billion and $9.0 billion, which is an increase from the previous guidance of 1 to 2 percent growth to 4 to 5 percent growth. The adjusted EBITDA margin is expected to be between 21.3% and 21.8%, and the adjusted EPS guidance has also been increased to a range of $4.70 to $4.85, up from $4.50 to $4.70. The company anticipates a free cash flow margin of approximately 9 to 10 percent for the year.

Jul 31, 2025 07:02:10

Xylem Reports Q1 2025 Revenue and Earnings Growth

Xylem Inc. reported first-quarter 2025 revenue of $2.1 billion, reflecting a 2% increase on a reported basis and a 3% increase organically. The company's earnings per share rose 10% to $0.69, with an adjusted figure of $1.03 representing a 14% increase. The growth was attributed to strong demand across all segments, despite some challenges from foreign exchange impacts. Additionally, the company achieved a net income margin of 8.2%, up 70 basis points from the previous year, driven by operational performance and reduced interest expenses.

The company reaffirmed its full-year adjusted earnings per share guidance, projecting a range of $4.50 to $4.70. Xylem expects revenue for the full year to be approximately $8.7 to $8.8 billion, indicating growth of 1-2% on a reported basis. The adjusted EBITDA margin is anticipated to be between 21.3% and 21.8%, showing an increase from 2024 results. Xylem's operational model transformation and strategic pricing efforts are aimed at maintaining resilience against current market volatility.

Apr 29, 2025 07:03:45

Xylem Reports $8.6 Billion Revenue for Full Year 2024

Xylem Inc. reported notable growth in its fourth-quarter and full-year results for 2024, with fourth-quarter orders and revenue reaching $2.2 billion and $2.3 billion respectively, both up 7% compared to the previous year. The company also achieved earnings per share of $1.34, a 22% increase, and a total revenue of $8.6 billion for the year, marking a 16% rise. Additionally, the net income margin improved to 14.5%, and the board declared a dividend increase of 11% for the first quarter of 2025, demonstrating a commitment to returning value to shareholders. 

However, the results were impacted by several negative factors, including a non-recurring gain on the remeasurement of an equity interest, which contributed to the net income but may not be sustainable. The company faced challenges such as increased restructuring costs and a loss on the sale of businesses, which partially offset operational gains. Furthermore, while the adjusted EBITDA margin improved, the company acknowledged ongoing inflation pressures and strategic investments that could affect future profitability.

Feb 04, 2025 07:03:26

Xylem Reports $2.1 Billion Revenue and $0.89 EPS in Q3

Xylem Inc. reported a revenue of $2.1 billion for the third quarter of 2024, reflecting a 1% increase compared to the previous year. The earnings per share rose significantly by 41% to $0.89, and the adjusted earnings per share saw a 12% increase to $1.11. Additionally, orders grew by 8%, indicating strong demand across all segments. The company also noted that margin expansion exceeded expectations, attributed to productivity savings and the integration of Evoqua, which is progressing ahead of schedule, enhancing their operational performance.

On the downside, the company narrowed its full-year adjusted earnings per share guidance from $4.18 to $4.28 to a new range of $4.22 to $4.24, suggesting some caution moving forward. The report highlighted moderated organic revenue growth, primarily due to project timing, which may impact future performance. Furthermore, while net income increased to $217 million, the overall growth in revenue was modest, which could raise concerns about sustaining higher growth rates in the upcoming quarters.

Oct 31, 2024 07:01:32